F8 ENT (ASX: 08347) has released its financial results for the fiscal year ended March 31, 2026. The company reported annual revenue of approximately HK$292 million, representing a decrease of 15.55% compared to the previous year.
The net loss for the period was HK$220,000, which marks a significant narrowing of 73.33% year-on-year. This resulted in a basic loss per share of HK$0.0016.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments